D-0292-2026 Class II Ongoing

Recalled by AvKARE — Pulaski, TN

FDA drug recall D-0292-2026 was initiated by AvKARE on Dec 31, 2025 and is designated Class II. Reason for recall: Out of specification for dissolution. The recall status is ongoing. Affected quantity: 7,991 5x10 cartons.

Recall details

Product Type
Drugs
Report Date
Jan 14, 2026
Initiation Date
Dec 31, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
7,991 5x10 cartons

Product description

Rosuvastatin Tablets, USP, 10 mg, Rx Only, 50 Tablets (5 x 10) Unit Dose per carton, Manufactured for: AvKARE, Pulaski, TN 38478. NDC: 50268-709-15

Reason for recall

Out of specification for dissolution.

Distribution pattern

Nationwide in the USA

Code information

Lot #49124, Exp Date 12/31/2026

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0292-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0292-2026. Report a data issue: hello@regdatalab.com.